These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 5812296)
1. An animal model for chlorpromazine-induced hyperpigmentation of the skin. Forrest IS; Aber RC; Kosek JC; Serra MT Proc West Pharmacol Soc; 1969; 12():36-40. PubMed ID: 5812296 [No Abstract] [Full Text] [Related]
2. Rabbit as a model for chlorpromazine-induced hyperpigmentation of the skin. Forrest IS; Kosek JC; Aber RC; Serra MT Biochem Pharmacol; 1970 Mar; 19(3):849-52. PubMed ID: 5507689 [No Abstract] [Full Text] [Related]
3. An animal model for the study of azidothymidine-induced hyperpigmentation. Roth RI; Baker G; Levin J Lab Invest; 1991 Mar; 64(3):437-9. PubMed ID: 2002660 [TBL] [Abstract][Full Text] [Related]
4. Chlorpromazine-induced skin pigmentation with corneal and lens opacities. Huff LS; Prado R; Pederson JF; Dunnick CA; Lucas LM Cutis; 2014 May; 93(5):247-50. PubMed ID: 24897137 [TBL] [Abstract][Full Text] [Related]
5. Effect of phenol on development of prolarvae of acipenserid fish. 3. Pigmentation of the skin. Structure of the eyes. Shmal'gauzen OI Sov J Dev Biol; 1973; 4(1):28-35. PubMed ID: 4778506 [No Abstract] [Full Text] [Related]
7. Long term evolution of the side-effect lens opacities induced by chlorpromazine prolonged therapy. Baron JB; Rivoalan Y; Morel P Agressologie; 1971; 12(1):57-60. PubMed ID: 5088348 [No Abstract] [Full Text] [Related]
8. Skin pigmentation and chlorpromazine. Zelickson AS JAMA; 1965 Nov; 194(6):670-2. PubMed ID: 5897244 [No Abstract] [Full Text] [Related]
9. Skin changes and chlorpromazine. Some hazards of long-term drug therapy. Zelickson AS JAMA; 1966 Oct; 198(4):341-4. PubMed ID: 5953251 [No Abstract] [Full Text] [Related]
10. Blue skin pigmentation and chlorpromazine. Haddad RI J Ky Med Assoc; 1977 Mar; 75(3):124-6. PubMed ID: 839129 [No Abstract] [Full Text] [Related]
11. Isolation of chlorpromazine pigments in man. Van Woert MH Nature; 1968 Sep; 219(5158):1054-6. PubMed ID: 5673364 [No Abstract] [Full Text] [Related]
13. An electron microscopic study of chlorpromazine pigmentation. Hashimoto K; Wiener W; Albert J; Nelson RG J Invest Dermatol; 1966 Oct; 47(4):296-306. PubMed ID: 5954160 [No Abstract] [Full Text] [Related]
14. Distribution of chlorpromazine metabolites in selected organs of psychiatric patients chronically dosed up to the time of death. Forrest IS; Bolt AG; Serra MT Biochem Pharmacol; 1968 Oct; 17(10):2061-70. PubMed ID: 5696876 [No Abstract] [Full Text] [Related]
15. [Ophthalmologic manifestations, with or without associated skin disorders, during prolonged treatment with chlorpromazine]. Baron JB; Morel P; Rivoallan Y; Soulairac A Agressologie; 1968; 9(2):293-304. PubMed ID: 5675496 [No Abstract] [Full Text] [Related]
16. Increasing our understanding of pigmentary disorders. Grimes P; Nordlund JJ; Pandya AG; Taylor S; Rendon M; Ortonne JP J Am Acad Dermatol; 2006 May; 54(5 Suppl 2):S255-61. PubMed ID: 16631966 [TBL] [Abstract][Full Text] [Related]
17. 7-HYDROXYCHLORPROMAZINE: POTENTIAL TOXIC DRUG METABOLITE IN PSYCHIATRIC PATIENTS. PERRY TL; CULLING CF; BERRY K; HANSEN S Science; 1964 Oct; 146(3640):81-3. PubMed ID: 14173037 [TBL] [Abstract][Full Text] [Related]